What is Driving the Growth of the Aortic Valve Replacement Devices Market?
The aortic valve replacement devices market focuses on medical devices used to replace malfunctioning aortic valves, often due to conditions like aortic stenosis or regurgitation. The market size was USD 8.99 Billion in 2024 and is expected to reach USD 16.88 Billion by 2034, growing at a CAGR of 6.50%.
Key growth drivers include:
-
Rising prevalence of cardiovascular diseases worldwide
-
Increasing geriatric population prone to aortic valve disorders
-
Advances in minimally invasive and transcatheter procedures
-
Expanding healthcare infrastructure and skilled cardiac surgeons
-
Growing awareness and adoption of innovative replacement devices
Aortic valve replacement devices are critical in restoring cardiac function, improving patient survival rates, and reducing complications related to severe aortic valve disease.
Market Overview
-
2024 Market Size: USD 8.99 Billion
-
2025 Market Forecast: USD 9.58 Billion
-
2034 Market Forecast: USD 16.88 Billion
-
CAGR (2025–2034): 6.50%
The market is segmented by surgery type, product type, end use, and region, offering detailed insights into adoption trends, technological advancements, and regional growth opportunities.
Breakup by Surgery Type
-
Open Surgery: Traditional approach involving sternotomy; preferred for complex cases
-
Minimally Invasive Surgery: Includes transcatheter and small-incision techniques; gaining popularity due to reduced recovery time and lower complication rates
Breakup by Product Type
-
Transcatheter Aortic Valve Replacement (TAVR): Rapidly growing segment, preferred for high-risk and elderly patients
-
Sutureless Aortic Valve Replacement (SUAVR): Designed for quicker implantation and reduced operative time, suitable for both open and minimally invasive approaches
Breakup by End Use
-
Hospitals: Major segment due to comprehensive cardiac care units and surgical facilities
-
Ambulatory Surgical Centres: Increasing adoption due to minimally invasive procedures
-
Others: Includes specialty cardiac centers and private clinics
Breakup by Region
1. North America
-
Largest market share driven by advanced healthcare infrastructure, high cardiovascular disease prevalence, and technology adoption
2. Europe
-
Growth supported by aging population, progressive healthcare policies, and high awareness about minimally invasive procedures
3. Asia Pacific
-
Fastest-growing region with increasing healthcare spending, rising incidence of cardiac diseases, and expanding surgical infrastructure
-
Key countries: China, Japan, India, South Korea
4. Latin America
-
Growth due to rising cardiovascular awareness, improved healthcare access, and government initiatives
5. Middle East & Africa
-
Emerging market opportunities driven by urbanization, healthcare investments, and increasing awareness of heart diseases
Market Trends and Opportunities
-
Shift Toward Minimally Invasive Procedures:
Transcatheter approaches are reducing recovery times and hospital stays, increasing patient preference. -
Technological Advancements in Valve Designs:
Focus on durable, sutureless valves with improved hemodynamic performance. -
Rising Geriatric Population:
Aging populations in North America, Europe, and Asia Pacific are fueling demand for aortic valve replacements. -
Expansion of Cardiac Care Infrastructure:
Investment in advanced cardiac hospitals and specialty centers is supporting device adoption. -
Growing Awareness and Early Diagnosis:
Early screening for aortic stenosis and valve dysfunction is driving timely surgical interventions.
Key Companies Covered
-
Boston Scientific Corporation
-
Corcym S.r.l
-
Edwards Lifesciences Corporation
-
Medtronic plc
-
Artivion, Inc.
-
Abbott Laboratories
-
Others
These companies focus on innovation in valve technology, global distribution, and strategic partnerships to strengthen their market presence.
Future Outlook
The aortic valve replacement devices market is projected to grow steadily through 2034 due to:
-
Rising prevalence of aortic stenosis and regurgitation
-
Adoption of minimally invasive and sutureless valve technologies
-
Expansion of cardiac surgery facilities in emerging markets
-
Technological improvements improving implantation efficiency and patient outcomes
-
Increasing public awareness and early screening programs
By 2034, the market is expected to reach USD 16.88 Billion, driven by both developed regions like North America and Europe and emerging markets in Asia Pacific.
Uncover More Reports
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.
Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
